Publication Name	世界华人消化杂志
手稿编号	39998
手稿来源省、自治区或特别行政区	浙江省

Received	2024-07-23 15:05
Peer-Review Started	2024-07-24 08:40
To Make the First Decision
Return for Revision	2024-08-20 01:21
修回稿	2024-08-23 09:35
Second Decision	2024-09-02 03:03
期刊总编辑接受
公司总编辑接受	2024-09-03 07:19
预出版	2024-09-03 07:19
缴纳版面费
Edit the Manuscript by Language Editor
排版	2024-09-27 08:56
在线出版	2024-09-28 13:34

ISSN	1009-3079 (print) and 2219-2859 (online)
开放获取	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
版权	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
网址	http://www.wjgnet.com

专业类型	消化基础研究
手稿栏目类型	基础研究
文章标题	miR-15a-5p靶向PD-L1对食管癌进展、预后与肿瘤免疫反应的影响
手稿来源	自由来稿
所有作者列表	林亭呈, 张婉君
基金项目及其编号
通讯作者	林亭呈, 本科, N/A, 318050, 浙江省台州市路桥区桐屿街道桐阳路1号台州恩泽医疗中心（集团）恩泽医院, 浙江省台州医院药剂科. 13777841314@163.com
关键词	miR-15a-5p; 食管癌; PD-L1; 预后; 肿瘤免疫反应
核心内容提要	微核糖核酸(microRNA, miR)-15a-5p与细胞程序性死亡蛋白配体1(programmed death-ligand 1, PD-L1)不仅是食管癌诊断及预后的潜在生物标记物, miR-15a-5p还能通过靶向PD-L1来增强CD8+ T细胞的活化.
出版日期	2024-09-28 13:34
引文著录	林亭呈, 张婉君. miR-15a-5p靶向PD-L1对食管癌进展、预后与肿瘤免疫反应的影响. 世界华人消化杂志 2024; 32(9): 678-685
URL	https://www.wjgnet.com/1009-3079/full/v32/i9/678.htm
DOI	https://dx.doi.org/10.11569/wcjd.v32.i9.678

Full Article (PDF)	WCJD-32-678-with-cover.pdf
审稿意见	WCJD-39998-Peer-review(s).pdf
科学编辑工作清单	WCJD-39998-Scientific editor work list.pdf